Lactobacillus plantarum OLL2712 regulates glucose metabolism in C57bl/6 mice fed a high-fat diet

Journal of Nutritional Science and Vitaminology

Volumn 59, Issue 2, 2013, Pages 144-147

  Sakai, Tohru ^a   Taki, Tomoyo ^a   Nakamoto, Akiko ^a   Shuto, Emi ^a   Tsutsumi, Rie ^a   Toshimitsu, Takayuki ^b   Makino, Seiya ^b   Ikegami, Shuuji ^b  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b MEIJI DAIRIES CORPORATION   (Japan)

Author keywords

Adipose tissue; Inflammation; Lactobacillus plantarum; Obesity

Indexed keywords

CHOLESTEROL; FATTY ACID; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BODY WEIGHT; CONTROLLED STUDY; ENZYME CHEMISTRY; GLUCOSE METABOLISM; LACTOBACILLUS PLANTARUM; LIPID DIET; MALE; MOUSE; NONHUMAN; NOTE; OBESITY; REAL TIME POLYMERASE CHAIN REACTION;

ADIPOSE TISSUE; ANIMALS; BLOOD GLUCOSE; CHOLESTEROL; DIET, HIGH-FAT; FATTY ACIDS, NONESTERIFIED; INSULIN; INTERLEUKIN-1BETA; LACTOBACILLUS PLANTARUM; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; OBESITY; PROBIOTICS; RNA, MESSENGER; TRIGLYCERIDES;

LACTOBACILLUS PLANTARUM; MUS;

EID: 84878434562     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.59.144     Document Type: Note

References (20)

1. Kahn SE, Hull RL, Utzschneider KM. 2006. Mechanism linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840-846.
2. Dèspres JP, Lemieux I. 2006. Abdominal obesity and metabolic syndrome. Nature 444: 881-887.
3. Dahabreh IJ, Economopoulos K. 2008. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular event in randomized trials of rosiglitazone. Clin Trials 5: 116-120.
4. Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. 2001. Probiotics: effect on immunity. Am J Clin Nutr 73: 444-450.
5. Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poll G, Karin M. 2005. IKK-b links inflammation to obesity-induced insulin resistance. Nat Med 11: 191-198.
6. Jager J, Grèmeaux T, Cormont M, Le Marchand-Brustel Y, Tanti JF. 2007. Interleukin-1b-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148: 241-251.
7. Larsen CM, Faulenbach M, Vaag A, Vølund A, Ehses JA, Selfert B, Mandrup-Poulsen T, Donath MY. 2007. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356: 1517-1526.
8. Osborn O, Brownell SE, Sanchez-Alavez M, Salomon D, Gram H, Bartiai T. 2008. Treatment with an interleukin 1b antibody improves glycemic control in diet-induced obesity. Cytokine 44: 141-148.
9. Vandanmagsar B, Youm Y-H, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM, Dixit VD. 2011. The NLRP3 inflammasome instigates obesityinduced inflammation and insulin resistance. Nat Med 17: 179-188.
10. Takemura N, Okubtero T, Sonoyama K. 2010. Lactobacillus plantarum strain No. 14 reduces adipocyte size in mice fed high-hat diet. Exp Biol Med 235: 849-856.
11. Kondo S, Xiao J-Z, Sato T, Odamaki T, Takahashi S, Sugawara H, Yaeshima T, Iwatsuki K, Kamei A, Abe K. 2010. Antiobesity effects of Bifidobacterium breve strain B-3 supplementation in a mouse model with highfat diet-induced obesity. Biosci Biotechnol Biochem 74: 1656-1661.
12. Lee H-Y, Park J-H, Seok S-H, Baek M-W, Kim D-J, Lee K-E, Paek K-S, Lee Y, Park J-H. 2006. Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Biochim Biophys Acta 1761: 736-744.
13. Hamada E, Sato M, Uzu K, Yoshida T, Higashi S, Kawakami H, Kadooka Y, Matsuyama H, El-Gawad IAA, Imaizumi K. 2009. Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucher rats. Br J Nutr 101: 716-724.
14. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. 2005. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 102: 11070-11075.
15. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. 2006. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444: 1027-1031.
16. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M, Otsu M, Hara K, Ueki K, Sugiura S, Yoshimura K, Kadowaki T, Nagai R. 2009. CD81 effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15: 914-920.
17. Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J, Dorfman R, Wang Y, Zielenski J, Mastronardi F, Maezawa Y, Drucker DJ, Engleman E, Winer D, Dosch HM. 2009. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 15: 921-929.
18. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A, Lee J, Goldfine AB, Benoist C, Shoelson S, Mathis D. 2009. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15: 930-940.
19. Makino S, Ikegami S, Kano H, Sashihara T, Sugano H, Hiriuchi H, Saito T, Oda M. 2006. Immunomodulatory effects of polysaccharides produced by Lactobacillus delbrueckii spp. Bulgaricus OLL1073R-1. J Dairy Sci 89: 2873-2881.
20. Gross ML, Stevenson LM, Gill HS. 2001. Anti-allergy properties of fermented foods: an important immunoregulatory mechanism of lactic acid bacteria. Int Immunopharmacol 1: 891-901.